PLoS One 2016
Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy.
Related Questions
In this case, I have a patient with widely metastatic cutaneous melanoma (BRAF wild type, NRAS mutated) who is progressing through pembrolizumab and i...
New comment by Radiation Oncologist at Mon Health ( January 29, 2022)
Thank you, what are your thoughts about 6 Gy x 5, every other day for a bleeding anorectal melanoma?